Gadolinium-based contrast agents (GBCAs) are widely used in clinical practice. However, there are growing concerns regarding the safety of GBCAs with recent findings of gadolinium deposition in patients with normal renal function. This educational exhibit reviews the use of gadolinium in children, including the safety profile, existing controversies, and potential solutions.
SPR 2017 Annual Meeting & Categorical Course
nephrogenic systemic fibrosis,
gadolinium deposition disease,